FDA inspection
Jubilant HollisterStier General Partnership: FDA inspection ending Oct 7, 2022
FDA inspection 1181741 · No Action Indicated (NAI) · Kirkland
Key facts
| Inspection ID | 1181741 |
|---|---|
| Firm | Jubilant HollisterStier General Partnership |
| FEI number | 3001623073 |
| Address | 16751 Rte Transcanadienne |
| City | Kirkland |
| Country | Canada |
| Fiscal year | 2023 |
| Inspection end date | Oct 7, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data